Single-Dose Ad26.COV2.S Vaccine-Room for Improvement

Zahra Rikhtegaran Tehrani¹, Mohammad M Sajadi^{1

2}

Affiliations

¹ Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore.
² Department of Medicine, Baltimore Veterans Affairs Medical Center, Baltimore, Maryland.

Free article

Comment

Zahra Rikhtegaran Tehrani et al. JAMA Netw Open. 2021.

Free article

. 2021 Nov 1;4(11):e2133012.

doi: 10.1001/jamanetworkopen.2021.33012.

Zahra Rikhtegaran Tehrani¹, Mohammad M Sajadi^{1

2}

¹ Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore.
² Department of Medicine, Baltimore Veterans Affairs Medical Center, Baltimore, Maryland.

No abstract available

Comment on

Analysis of the Effectiveness of the Ad26.COV2.S Adenoviral Vector Vaccine for Preventing COVID-19.
Corchado-Garcia J, Zemmour D, Hughes T, Bandi H, Cristea-Platon T, Lenehan P, Pawlowski C, Bade S, O'Horo JC, Gores GJ, Williams AW, Badley AD, Halamka J, Virk A, Swift MD, Wagner T, Soundararajan V. Corchado-Garcia J, et al. JAMA Netw Open. 2021 Nov 1;4(11):e2132540. doi: 10.1001/jamanetworkopen.2021.32540. JAMA Netw Open. 2021. PMID: 34726743 Free PMC article.